These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 4543206)

  • 21. [Heredity of familial oxalosis].
    Lindenmayer JP
    J Genet Hum; 1970 May; 18(1):31-43. PubMed ID: 5516286
    [No Abstract]   [Full Text] [Related]  

  • 22. Inborn errors of metabolism. Variability within single diseases.
    Danks DM
    Clin Pediatr (Phila); 1971 Jan; 10(1):1-3. PubMed ID: 5545904
    [No Abstract]   [Full Text] [Related]  

  • 23. [Fatal congenital hypophosphatasia].
    Péter J; Ferenczy I; Görgényi A; Machay T
    Orv Hetil; 1972 Jan; 113(5):258-60. PubMed ID: 5058493
    [No Abstract]   [Full Text] [Related]  

  • 24. Asymptomatic and late-onset ornithine transcarbamylase deficiency caused by a A208T mutation: clinical, biochemical and DNA analyses in a four-generation family.
    Ausems MG; Bakker E; Berger R; Duran M; van Diggelen OP; Keulemans JL; de Valk HW; Kneppers AL; Dorland L; Eskes PF; Beemer FA; Poll-The BT; Smeitink JA
    Am J Med Genet; 1997 Jan; 68(2):236-9. PubMed ID: 9028466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Changes of urinary excretion of orotic acid in a patient with ornithine carbamyl transferase deficiency].
    Sakane Y; Sugimoto T
    Rinsho Byori; 1982 May; 30(5):547-50. PubMed ID: 7131821
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hereditary anomalies of the urea cycle].
    Berger R; Broyer M
    Presse Med (1893); 1968 May; 76(24):1183-4. PubMed ID: 5673388
    [No Abstract]   [Full Text] [Related]  

  • 27. The field investigation for acatalasemic gene carriers.
    Wakisaka G; Yamamoto T; Yamamoto Y; Sakamoto K; Sawada M
    Naika Hokan; 1967 May; 14(5):151-7. PubMed ID: 5624288
    [No Abstract]   [Full Text] [Related]  

  • 28. The ornithine transcarbamylase (OTC) gene: mutations in 50 Japanese families with OTC deficiency.
    Matsuda I; Tanase S
    Am J Med Genet; 1997 Sep; 71(4):378-83. PubMed ID: 9286441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperammonemia due to a mutant enzyme of ornithine transcarbamylase.
    Matsuda I; Arashima S; Nambu H; Takekoshi Y; Anakura M
    Pediatrics; 1971 Oct; 48(4):595-600. PubMed ID: 5114747
    [No Abstract]   [Full Text] [Related]  

  • 30. Hypocitrullinemia in expanded newborn screening by LC-MS/MS is not a reliable marker for ornithine transcarbamylase deficiency.
    Cavicchi C; Malvagia S; la Marca G; Gasperini S; Donati MA; Zammarchi E; Guerrini R; Morrone A; Pasquini E
    J Pharm Biomed Anal; 2009 Jul; 49(5):1292-5. PubMed ID: 19359120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and biochemical heterogeneity in females of a large pedigree with ornithine transcarbamylase deficiency due to the R141Q mutation.
    Ahrens MJ; Berry SA; Whitley CB; Markowitz DJ; Plante RJ; Tuchman M
    Am J Med Genet; 1996 Dec; 66(3):311-5. PubMed ID: 8985493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hyperammonemia due to an inborn error of metabolism. Ornithine-transcarbamylase deficiency].
    Chevrel B
    Presse Med (1893); 1969 Sep; 77(40):1370. PubMed ID: 5821578
    [No Abstract]   [Full Text] [Related]  

  • 33. A novel complex mutation of the OTC (ornithine transcarbamylase) gene in a Malaysian pedigree.
    Khoo AS; Balraj P; Rachedi A; Chin CN; Volpi L
    Hum Mutat; 1999 Nov; 14(5):448. PubMed ID: 10533073
    [No Abstract]   [Full Text] [Related]  

  • 34. Urea cycle disorders: diagnosis, pathophysiology, and therapy.
    Brusilow SW; Maestri NE
    Adv Pediatr; 1996; 43():127-70. PubMed ID: 8794176
    [No Abstract]   [Full Text] [Related]  

  • 35. [ 1 -antitrypsin-genotype determination. Studies in 2 families].
    Hofmann S; Grob PJ; Hany A
    Schweiz Med Wochenschr; 1973 Jan; 103(3):100-7. PubMed ID: 4683516
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinico-biological therapeutic effect of intramuscular ornithine-carbamyl-transferase in chronic active hepatitis].
    Sanchís Closa A; Caballería Rovira E; Arago López JV; Massó Ubeda RM
    Rev Esp Enferm Apar Dig; 1988 Apr; 73(4):351-4. PubMed ID: 3387645
    [No Abstract]   [Full Text] [Related]  

  • 37. [Sex difference in inborn errors of metabolism and epilepsy].
    Kodama H; Kamoshita S
    No To Shinkei; 1983 Sep; 35(9):877-85. PubMed ID: 6651986
    [No Abstract]   [Full Text] [Related]  

  • 38. Hereditary metabolic disorders involving the urea cycle.
    Levin B; Dobbs RH
    Proc R Soc Med; 1968 Aug; 61(8):773-4. PubMed ID: 5673401
    [No Abstract]   [Full Text] [Related]  

  • 39. [Therapeutic use of ornithine-carbamyl-transferase in liver diseases].
    Maccá F; Gatta A; Caregaro L; Lauro S; Milani L; Zuin R; Menozzi L
    Minerva Dietol Gastroenterol; 1982; 28(1):71-8. PubMed ID: 7078779
    [No Abstract]   [Full Text] [Related]  

  • 40. Seven novel mutations in the ORNT1 gene (SLC25A15) in patients with hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome.
    Salvi S; Dionisi-Vici C; Bertini E; Verardo M; Santorelli FM
    Hum Mutat; 2001 Nov; 18(5):460. PubMed ID: 11668643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.